Search

Randal V Kaufman

from Oceanside, CA
Age ~54

Randal Kaufman Phones & Addresses

  • 330 Spring Canyon Way, Oceanside, CA 92057 (760) 754-9092
  • San Marcos, CA
  • San Luis Rey, CA
  • 453 Oak Ave, Redwood City, CA 94061 (650) 299-9444 (650) 299-9555
  • Burlingame, CA
  • San Diego, CA
  • San Mateo, CA

Professional Records

Medicine Doctors

Randal Kaufman Photo 1

Randal B. Kaufman

View page
Specialties:
Cardiovascular Disease
Work:
Primary Cardiology Of Attleboro
150 Emory St UNIT 4, Attleboro, MA 02703
(508) 699-1025 (phone), (508) 809-9552 (fax)
Education:
Medical School
Boston University School of Medicine
Graduated: 1980
Procedures:
Cardiac Rehabilitation
Cardiac Stress Test
Continuous EKG
Echocardiogram
Electrocardiogram (EKG or ECG)
Vaccine Administration
Conditions:
Abdominal Hernia
Acute Bronchitis
Acute Myocardial Infarction (AMI)
Acute Pancreatitis
Acute Pharyngitis
Languages:
English
Description:
Dr. Kaufman graduated from the Boston University School of Medicine in 1980. He works in Attleboro, MA and specializes in Cardiovascular Disease. Dr. Kaufman is affiliated with Sturdy Memorial Hospital.

Resumes

Resumes

Randal Kaufman Photo 2

Sales Director

View page
Location:
San Diego, CA
Industry:
Electrical/Electronic Manufacturing
Work:
Black & Veatch
Sales Director

Abb Aug 2014 - May 2018
Regional Sales Manager

Clearedge Power Oct 2011 - 2014
Area Sales Manager and Project Development

Apc By Schneider Electric Mar 2010 - Sep 2011
District Manager

Tima Power Systems Mar 2009 - Mar 2010
Regional Sales Manager
Education:
University of California, Irvine - the Paul Merage School of Business 2008 - 2010
Master of Business Administration, Masters, International Business
California State University, Chico 1988 - 1993
Bachelors, Bachelor of Arts, International Relations
Uc Irvine
Master of Business Administration, Masters, Business, International Business
Skills:
Data Center
Sales
Business Development
Energy Management
New Business Development
Project Management
Solution Selling
Strategic Planning
Ups Systems
Business Strategy
Channel Partners
Management
Networking
Product Development
Integration
Sales Management
Contract Negotiation
Energy
Project Planning
Account Management
Direct Sales
Cross Functional Team Leadership
Competitive Analysis
Product Management
Strategic Partnerships
Construction
Budgets
Strategy
Program Management
Energy Efficiency
Start Ups
Telecommunications
Marketing
Product Marketing
Alternative Energy
Selling
Business Planning
Salesforce.com
Crm
Team Leadership
Cloud Computing
Technical Sales
Channel Management
Negotiation
Disaster Recovery
Operations Management
Marketing Strategy
Sales Operations
Customer Relationship Management
Languages:
Spanish
Randal Kaufman Photo 3

Randal Kaufman

View page

Business Records

Name / Title
Company / Classification
Phones & Addresses
Randal Kaufman
Managing
Tnk Associates, LLC
Consulting · Consulting Technical Services · Consulting Wholesale Sales · Business Services · Management Consulting Services
125 Old Grv Rd, Oceanside, CA 92057
330 Spg Cyn Way, Oceanside, CA 92057
121 Old Grv Rd, Oceanside, CA 92057

Publications

Us Patents

Inactivation Resistant Factor Viii

View page
US Patent:
20130072434, Mar 21, 2013
Filed:
Jul 5, 2012
Appl. No.:
13/542010
Inventors:
Randal J. Kaufman - San Diego CA, US
Steven W. Pipe - Ypsilanti MI, US
Assignee:
UNIVERSITY OF MICHIGAN - Ann Arbor MI
International Classification:
C07K 14/755
A61K 38/37
US Classification:
514 141, 530383
Abstract:
The present invention provides novel purified and isolated nucleic acid sequences encoding procoagulant-active FVIII proteins. The nucleic acid sequences may encode amino acid sequences corresponding to known human FVIII sequences, wherein residue Phe309 is mutated. The nucleic acid sequences also may encode amino acid sequences corresponding to known human FVIII sequences, wherein the APC cleavage sites, Arg336 and Ile562, are mutated. The nucleic acid sequences of the present invention further encode amino acid sequences corresponding to known human FVIII sequences, wherein the B-domain is deleted, the von Willebrand factor binding site is deleted, a thrombin cleavage site is mutated, an amino acid sequence spacer is inserted between the A2- and A3-domains. Provided herein are methods of producing the FVIII proteins of the invention, nucleotide sequences encoding such proteins, pharmaceutical compositions containing the nucleotide sequences or proteins, as well as methods of treating patients suffering from hemophilia.

Expression Of Pace In Host Cells And Methods Of Use Thereof

View page
US Patent:
59860790, Nov 16, 1999
Filed:
Jun 7, 1995
Appl. No.:
8/480382
Inventors:
Philip J. Barr - Berkeley CA
Anthony J. Brake - Berkeley CA
Randal J. Kaufman - Boston MA
Louise Wasley - Medfield MA
Polly A. Wong - Mountain View CA
Assignee:
Genetics Institute, Inc. - Cambridge MA
Chiron Corporation - Emeryville CA
International Classification:
C12N 1557
C12N 1579
C12N 1585
C12N 964
US Classification:
536 232
Abstract:
Compositions and methods are provided for endopeptidase production and for enhanced efficiencies of processing heterologous precursor polypeptides to mature polypeptides, including proteins requiring gamma-carboxylation for biological activity. These compositions and methods utilize recombinant PACE, a mammalian endopeptidase that is specific for dibasic amino acid sites.

Expression Of Pace In Host Cells And Methods Of Use Thereof

View page
US Patent:
59654252, Oct 12, 1999
Filed:
Nov 8, 1996
Appl. No.:
8/745880
Inventors:
Philip J. Barr - Berkeley CA
Anthony J. Brake - Berkeley CA
Randal J. Kaufman - Boston MA
Louise Wasley - Medfield MA
Polly A. Wong - Mountain View CA
Assignee:
Genetics Institute, Inc. - Cambridge MA
Chiron Corporation - Emeryville CA
International Classification:
C12N 964
C12N 948
C12N 1557
C12N 1579
US Classification:
435226
Abstract:
Compositions and methods are provided for endopeptidase production and for enhanced efficiencies of processing heterologous precursor polypeptides to mature polypeptides, including proteins requiring gamma-carboxylation for biological activity. These compositions and methods utilize recombinant PACE, a mammalian endopeptidase that is specific for dibasic amino acid sites.

Expression Of Pace In Host Cells And Methods Of Use Thereof

View page
US Patent:
54609500, Oct 24, 1995
Filed:
May 20, 1992
Appl. No.:
7/885972
Inventors:
Philip J. Barr - Berkeley CA
Anthony J. Brake - Berkeley CA
Randal J. Kaufman - Boston MA
Louise Wasley - Medfield MA
Polly A. Wong - Mountain View CA
Assignee:
Genetics Institute, Inc. - Cambridge MA
Chiron Corporation - Emeryville CA
International Classification:
G12N 1500
G12N 1557
G12N 1581
G12N 1585
US Classification:
435 691
Abstract:
Compositions and methods are provided for endopeptidase production and for enhanced efficiencies of processing heterologous precursor polypeptides to mature polypeptides, including proteins requiring gamma-carboxylation for biological activity. These compositions and methods utilize recombinant PACE, a mammalian endopeptidase that is specific for dibasic amino acid sites.

Methods And Compositions For Binding Immunoglobulin Protein Targeting

View page
US Patent:
20230039930, Feb 9, 2023
Filed:
Dec 31, 2020
Appl. No.:
17/790052
Inventors:
- La Jolla CA, US
Randal J. KAUFMAN - San Diego CA, US
International Classification:
A01K 67/027
Abstract:
Models and methods related to targeting binding immunoglobulin protein (BiP) are described, where the models and methods allow identification and analysis of protein folding and misfolding.

Compounds And Methods For Activating The Apoptotic Arm Of The Unfolded Protein Response

View page
US Patent:
20170334889, Nov 23, 2017
Filed:
Aug 9, 2017
Appl. No.:
15/672574
Inventors:
- Lawrence KS, US
- Ann Arbor MI, US
- Detroit MI, US
- La Jolla CA, US
Randal J. Kaufman - San Diego CA, US
Thomas D.Y. Chung - Carlsbad CA, US
Anthony B. Pinkerton - San Diego CA, US
Michael Pablo Hedrick - Carlsbad CA, US
International Classification:
C07D 405/12
C07C 303/36
A61K 45/06
A61K 31/5377
A61K 31/496
C07D 307/71
A61K 31/4525
Abstract:
N-substituted sulfonylphenyl-5-nitrofuranyl-2-carboxamide derived compounds, which selectively activate the apoptotic, but not the adaptive arm, of the Unfolded Protein Response are provides as is their use in the treatment of diseases such as diabetes, Alzheimer's, Parkinson's, hemophilia, lysosomal storage diseases and cancer.

Compounds And Methods For Activating The Apoptotic Arm Of The Unfolded Protein Response

View page
US Patent:
20150203477, Jul 23, 2015
Filed:
Jun 18, 2013
Appl. No.:
14/408736
Inventors:
- Lawrence KS, US
- Ann Arbor MI, US
- Detroit MI, US
- La Jolla CA, US
Randal J. Kaufman - San Diego CA, US
Thomas D.Y. Chung - Carlsbad CA, US
Anthony B. Pinkerton - San Diego CA, US
Michael Pablo Hedrick - Carlsbad CA, US
International Classification:
C07D 405/12
C07C 303/36
A61K 45/06
A61K 31/5377
A61K 31/496
C07D 307/71
A61K 31/4525
Abstract:
N-substituted sulfonylphenyl-5-nitrofuranyl-2-carboxamide derived compounds, which selectively activate the apoptotic, but not the adaptive arm, of the Unfolded Protein Response are provides as is their use in the treatment of diseases such as diabetes, Alzheimer's, Parkinson's, hemophilia, lysosomal storage diseases and cancer.
Randal V Kaufman from Oceanside, CA, age ~54 Get Report